27 Nov 2019 --- Canapure, Symrise’s new active cannabidiol (CBD) ingredient is the latest addition to the company’s product portfolio of approved ingredients. According to the company, as the active pharmaceutical ingredient undergoes a synthetic production, it is highly similar to natural CBD and free of pesticides and environmental impurities. CBD is non-psychoactive and is said to have a relaxing, anti-inflammatory, anxiolytic and nausea-relieving effect on users upon consumption.
